Ticker
BBP
Asset Class
Equity
Assets Under Management
44.87M
Issuer
Virtus
Expense Ratio
79.00%
Inception Date
16-12-2014
Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S.
Loading chart…